Mechanisms of augmentation of contact allergic reactions by irritants and contact allergens
刺激物和接触性过敏原增强接触性过敏反应的机制
基本信息
- 批准号:335858052
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:德国
- 项目类别:Research Grants
- 财政年份:2017
- 资助国家:德国
- 起止时间:2016-12-31 至 2020-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Irritant (ICD) and allergic contact dermatitis (ACD) are inflammatory eczematous skin diseases which are induced by xenobiotic chemicals. They belong to the most important occupation-related skin diseases. An essential component of the pathomechanism is the activation of the innate immune system by so-called danger signals. These can be ligands for pattern recognition receptors such as the Toll-like receptors (TLR), or cellular proteins, nucleic acids, ATP and extracellular matrix components. Activation of the innate immune system results in skin inflammation and, consequently, in ACD, in the priming of contact allergen-specific T cells. Since the danger signals do not have to be induced solely or in part by the ACD-causing chemical other chemicals which also elicit danger signals can cause the replacement of missing or the augmentation of weak danger signals. This can result in unexpected sensitizations and ACD by rather weak contact allergens. Consumer products such as cosmetics, but also many working materials normally contain a number of different chemicals the combination of which may be responsible for such augmentation effects.In this project we will analyze such augmentation effects and their impact on the sensitization and elicitation phase of ACD by using defined chemical combinations. The goal of this project is the elucidation of the mechanistic basis of augmentation effects, establishment of an in vitro test system and improvement of the prevention by identification of hazards and risk assessment for the protection of the consumer and workers in occupations at risk.
过敏性接触性皮炎(ACD)和刺激性皮炎(ICD)是由外源性化学物质引起的炎症性湿疹性皮肤病。它们属于最重要的职业性皮肤病。病理机制的一个重要组成部分是所谓的危险信号激活先天免疫系统。这些可以是模式识别受体如Toll样受体(TLR)或细胞蛋白质、核酸、ATP和细胞外基质组分的配体。先天免疫系统的激活导致皮肤炎症,并因此导致ACD,导致接触性过敏原特异性T细胞的引发。由于危险信号不必完全或部分地由引起ACD的化学品引起,因此也引起危险信号的其他化学品可以引起缺失的危险信号的替代或微弱的危险信号的增强。这可能会导致意外的过敏和ACD相当弱的接触过敏原。化妆品等消费品以及许多工作材料通常含有许多不同的化学物质,这些化学物质的组合可能导致这种增强效应。在本项目中,我们将通过使用定义的化学组合来分析这种增强效应及其对ACD致敏和激发阶段的影响。该项目的目标是阐明增强效应的机械基础,建立体外测试系统,通过识别危害和风险评估改进预防工作,以保护消费者和从事危险职业的工人。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
IRE1 and PERK signaling regulates inflammatory responses in a murine model of contact hypersensitivity
- DOI:10.1111/all.15024
- 发表时间:2021-08-07
- 期刊:
- 影响因子:12.4
- 作者:Gendrisch, Fabian;Voelkel, Lukas;Esser, Philipp R.
- 通讯作者:Esser, Philipp R.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Professor Dr. Stefan Martin其他文献
Professor Dr. Stefan Martin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Professor Dr. Stefan Martin', 18)}}的其他基金
Mechanisms of age-dependent loss of resistance to allergic contact dermatitis in mice with innate immune system defects
先天免疫系统缺陷小鼠年龄依赖性过敏性接触性皮炎抵抗力丧失的机制
- 批准号:
342594883 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Research Grants
Aktivierung und Regulation Autoantigen-spezifischer T-Zellen beim Bullösen Pemphigoid
大疱性类天疱疮自身抗原特异性 T 细胞的激活和调节
- 批准号:
25106291 - 财政年份:2006
- 资助金额:
-- - 项目类别:
Research Grants
T-Zellinstruktion zu Gewebs-spezifischer Migration
T 细胞指令进行组织特异性迁移
- 批准号:
18714257 - 财政年份:2006
- 资助金额:
-- - 项目类别:
Research Grants
相似海外基金
LUMINOUS - Language Augmentation for Humanverse
LUMINOUS - Humanverse 的语言增强
- 批准号:
10106564 - 财政年份:2024
- 资助金额:
-- - 项目类别:
EU-Funded
高齢頚髄損傷の治療成績改善にむけた非侵襲血圧維持療法BP augmentationの開発
开发血压升高疗法,一种无创血压维持疗法,可改善老年颈脊髓损伤的治疗效果
- 批准号:
24K12323 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
STTR Phase II: Thermal Imaging, Augmentation of Microwave Energy in Various Tissues and Chronic Safety
STTR 第二阶段:热成像、增强各种组织中的微波能量和长期安全性
- 批准号:
2301440 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Cooperative Agreement
CAREER: Robotic Augmentation of Human Reflexes and Reach through Collaborative Grasping
职业:通过协作抓取机器人增强人类反应和触及范围
- 批准号:
2237843 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Standard Grant
SBIR Phase II: Arctic Environmental Modeling with Augmentation and Curation from an Artificial Intelligence Engine
SBIR 第二阶段:通过人工智能引擎进行增强和管理的北极环境建模
- 批准号:
2213136 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Cooperative Agreement
All for data, data for all: Improving accessibility of healthcare data through a co-designed augmentation of an existing online rehabilitation application.
一切为了数据,数据为所有人:通过共同设计的现有在线康复应用程序的增强功能,提高医疗保健数据的可访问性。
- 批准号:
10054277 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant for R&D
An Encepholographic Investigation of Spatial Cue Augmentation
空间线索增强的脑电图研究
- 批准号:
2899635 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Studentship
Prime editing for Crumbs homologue 1 (CRB1) Inherited Retinal Dystrophies
Crumbs 同源物 1 (CRB1) 遗传性视网膜营养不良的 Prime 编辑
- 批准号:
10636325 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Genome Editing Therapy for Usher Syndrome Type 3
针对 3 型亚瑟综合症的基因组编辑疗法
- 批准号:
10759804 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Evaluating the efficacy of Butyric acid pro-drug nanoparticle in retinal neuroprotection
评估丁酸前药纳米颗粒在视网膜神经保护中的功效
- 批准号:
10602346 - 财政年份:2023
- 资助金额:
-- - 项目类别: